Source: Annual Congress 2011 - Genetics of airway diseases and treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Hijikata, I. Matsushita, H. Ito, J. Ohashi, S. Homma, Y. Taguchi, A. Azuma, S. Kudoh, N. Keicho (Tokyo, Ibaraki, Nara, Japan). Genetic analysis of two novel mucin-like genes in the disease-susceptibility locus for diffuse panbronchiolitis. Eur Respir J 2011; 38: Suppl. 55, 447

Member's Comments

No comment yet.

Related content which might interest you: Positional cloning on 19q13 identifies UPAR as a potential asthma susceptibility gene Source: Eur Respir J 2007; 30: Suppl. 51, 37s Year: 2007 Human exome analysis of candidate genetic variants for susceptibility to high-altitude pulmonary edema in Japanese Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 Identification and analysis of rare and novel mutations of the alpha-1-antitrypsin gene Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 An informative intragenic microsatellite marker suggests the IL-1 receptor as a genetic modifier in cystic fibrosis Source: Eur Respir J, 50 (6) 1700426; 10.1183/13993003.00426-2017 Year: 2017 Susceptibility genes for lung diseases in the major histocompatibility complex revealed by lung expression quantitative trait loci analysis Source: Eur Respir J 2016; 48: 573-576 Year: 2016 Identification of multiple asthma susceptibility loci within the lmr1 locus on mouse chromosome 17 Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 Is the BTNL2 genotype associated with specific HLA-DRB1 and DRB3/4/5 alleles in Danish sarcoidosis patients? Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Disease modifier genes in cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=50 Year: 2006 Association between BTNL2 and sarcoidosis evolution is secondary to HLA-DRB1* alleles Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases Year: 2009 Linkage and haplotype analyses for chemokine receptors clustered in chromosome 3q21.3 in family pedigrees with asthma and atopy Source: Eur Respir J 2004; 24: Suppl. 48, 135s Year: 2004 Genome-wide association analysis reveals 12q13.3–q14.1 as new risk locus for sarcoidosis Source: Eur Respir J 2013; 41: 888-900 Year: 2013 A genetic landscape of familial predisposition to sarcoidosis identified by whole exome sequencing Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways Year: 2017 Evaluation of ANXA11 rs1049550 SNP linkage with sarcoidosis susceptibility Source: Annual Congress 2012 - Sarcoidosis Year: 2012 Identification of novel rare genetic variants associated with COPD in the general population Source: International Congress 2018 – Multiomics studies in epidemiology: what can they tell us? Year: 2018 Human genetic variability and susceptibility to pulmonary TB Source: Eur Respir Mon 2012; 58: 38-58 Year: 2012 Investigating the role of IREB2 genetic variants in susceptibility to COPD Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012 Large phenotypic spectrum associated with two new deep intronic variants on the CFTR gene Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Homozygous variant rs2076530 of BTNL2 and familial sarcoidosis: analysis of 5 members of a family Source: Annual Congress 2007 - Novel genetic markers in pathology Year: 2007 Polymorphism and copy number variation of FCGR genes in an etiopathogenesis of sarcoidosis Source: International Congress 2016 – Sarcoidosis Year: 2016 Genetic polymorphism of FOXP3 gene in sarcoidosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006